Wednesday, December 05, 2007

Biogen Takeover at 22% Premium Seen Justified by Drug Pipeline
Bloomberg - USA
Biogen researchers believe the compound, BG-12, works by tamping down inflammation, while also protecting healthy cells. It would be used for relapsing, ...
See all stories on this topic

Early Treatment With COPAXONE Demonstrated Robust Protection Against Progression To Clinically Definite Multiple ...
Medical News Today Wed, 05 Dec 2007 5:05 AM PST
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced the positive results from a pre-planned interim analysis of the PreCISe trial in patients presenting with a first clinical event and MRI features suggestive of multiple sclerosis (MS). [click link for full article]


Teva's Copaxone reduces risk of developing MS
PharmaBiz Tue, 04 Dec 2007 11:32 PM PST
Teva Pharmaceutical Industries Ltd. said its Copaxone reduced the risk of developing multiple sclerosis (MS) in patients with a first clinical event and MRI features.

Early Treatment With COPAXONE Demonstrated Robust Protection Against Progression To Clinically Definite Multiple Sclerosis In The PreCISe Study
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced the positive results from a pre-planned interim analysis of the PreCISe trial in patients presenting with a first clinical event and MRI features suggestive of multiple sclerosis (MS).05 Dec 2007

PET and bioluminescent imaging aid evaluation of stem cells ...
HealthTech Wire (press release) - Berlin,Germany
... bone marrow stem cells may help regenerate cells in individuals with heart disease (heart attacks) or brain disorders (strokes, multiple sclerosis) or ...
See all stories on this topic

Sainsbury Trust Funds "Vital" MS Research
PR Newswire UK (press release) - London,UK
The THC study is a randomised trial in 500 people with Primary and Secondary Progressive MS and one of around 50 research projects funded by the MS Society. ...
See all stories on this topic

Sector Glance: MS Drug Makers
Houston Chronicle - United States
One the doctors noted that Acorda's investigational sustained-release tablet, fampridine-SR, should see widespread usage in spinal cord injury patients, ...
See all stories on this topic

Mississippi Mother Pays Tribute to Lost Love with Wildlife ...
Reuters - USA
The idea was inspired after Janet shared in her husband's losing battle with Multiple Sclerosis since he was first diagnosed with primary progressive MS in ...
See all stories on this topic

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home